Bandaram Pharma Packtech Ltd (BANDARAM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Bandaram Pharma Packtech Ltd on NSE and BSE, with an AI summary of each filing.
Outcome of Board Meeting held on 29.10.2026
Outcome · 30 Oct 2026, 1:48 am
Bandaram Pharma Packtech Reports Q2 FY27 Financial Results Bandaram Pharma Packtech Limited reported consolidated revenue from operations of Rs 2,145.02 lakhs for the quarter ended 30th Sep'26, up 56.3% YoY from Rs 1,372.48 lakhs, but down 10.4% QoQ from Rs 2,395.26 lakhs. Consolidated net profit reached Rs 18.61 lakhs compared to Rs 6.03 lakhs in the year-ago period. For H1 ended 30th Sep'26, consolidated revenue surged 108.0% YoY to Rs 4,540.28 lakhs with net profit of Rs 87.05 lakhs. Standalone operations posted a net loss of Rs 41.04 lakhs on revenue of Rs 236.61 lakhs in Q2.
Results for Quater and half- year ended 30.09.2026
Financial Result · 30 Oct 2026, 1:45 am
Bandaram Pharma Packtech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 2,145 (+56.3% YoY | -10.4% QoQ) ■ EBITDA: 116 (+153.2% YoY | -25.0% QoQ) ■ EBITDA Margin (%): 5.4 (+207 bps YoY | -105 bps QoQ) ■ PAT: -22.1 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -0.12 (Profit to Loss YoY | Profit to Loss QoQ)
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve 1. Un-audited standalone ....
Intimation · 29 Oct 2026, 5:30 am
Bandaram Pharma Packtech Schedules Board Meeting on 29th Oct'26 for Q2 Results Bandaram Pharma Packtech Limited will convene its Board of Directors meeting on 29th Oct'26 to consider and approve the un-audited standalone and consolidated financial results, along with the Limited Review Report, for the quarter ended 30th Sep'26. In compliance with SEBI Insider Trading regulations, the company's trading window for dealing in securities remains closed from 1st Oct'26 until 48 hours post-declaration of the quarterly results for designated insiders, connected persons, and directors.
Cancellation of Board Meeting to be held on 30.09.2026
Others (Uncategorized) · 30 Sept 2026, 11:35 pm
Bandaram Pharma Packtech Cancels Board Meeting Scheduled for 30th Sep'26 Bandaram Pharma Packtech Limited informed BSE that its Board of Directors meeting scheduled for 30th Sep'26 has been cancelled due to unavoidable reasons.
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2026 ,inter alia, to consider and approve Intimation of Board ....
Intimation · 27 Sept 2026, 2:27 am
Bandaram Pharma Packtech Board to Consider Scheme of Arrangement and Amalgamation Bandaram Pharma Packtech Limited announced that its Board of Directors will meet on 30th Sep'26 to evaluate and consider a proposal for a Scheme of Arrangement/Amalgamation. Pursuant to SEBI Prohibition of Insider Trading regulations, the trading window for dealing in company securities is closed from 27th Sep'26 until 48 hours post the declaration of the board meeting outcome for all designated persons and insiders.
Scrutinizer''s Report of the AGM for the FY 2025-26
Annual General Meeting · 24 Sept 2026, 9:45 pm
Proceedings of AGM for the FY 2025-26
Annual General Meeting · 24 Sept 2026, 9:40 pm
Annual Report for the FY 2025-26.
Others (Uncategorized) · 01 Sept 2026, 11:40 pm
Notice of AGM for the FY 2025-26 Scheduled To Be Held on 24.09.2026.
Annual General Meeting · 01 Sept 2026, 11:32 pm
Change in Management
Change in Management · 13 Aug 2026, 11:57 pm
Bandaram Pharma Q1FY27 Results, Board Approvals, and AGM Date Bandaram Pharma reported a consolidated net profit of ₹68.44 lakhs for Q1FY27 ended 30 Jun'26, compared to a profit of ₹8.66 lakhs YoY. Consolidated revenue from operations stood at ₹2,395.29 lakhs. The board approved the unaudited financial results and confirmed the FY26 Annual General Meeting will be held via OAVM on 18 Sep'26. Key appointments include the re-appointment of Mr. Suryaprakasa Rao Bommisetti as Independent Director and M/s. M.M. Reddy & Co. as statutory auditors, subject to member approval at the AGM.
Un-Audited Financial Results (Standalone & Consolidated) for Quater ended 30.06.2026
Financial Result · 13 Aug 2026, 11:52 pm
Bandaram Pharma Packtech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 2,395 (+195.6% YoY | -8.8% QoQ) ■ EBITDA: 154 (+145.2% YoY | +89.6% QoQ) ■ EBITDA Margin (%): 6.4 (-133 bps YoY | +335 bps QoQ) ■ PAT: 18.9 (+1290.4% YoY | +297.3% QoQ) ■ EPS (INR): 0.11 (+450.0% YoY | +120.0% QoQ)
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. Un-Audited standalone ....
Intimation · 13 Aug 2026, 5:30 am
Bandaram Pharma Board Meeting on 13-Aug-26 to Approve Q1FY27 Financial Results Bandaram Pharma Packtech's Board of Directors will meet on 13-Aug-26 to consider and approve the un-audited standalone and consolidated financial results for the quarter ending 30-Jun-26. The company also announced that the trading window for insiders has been closed since 01-Jul-26. It will reopen 48 hours after the declaration of the financial results.
Clarification of Price Movement
Others (Uncategorized) · 07 Jul 2026, 11:08 pm
Bandaram Pharma Clarifies Share Price Movement In response to a BSE query on 06-Jul-26 regarding its recent share price increase, Bandaram Pharma Packtech Limited stated on 07-Jul-26 that there are no undisclosed events or price-sensitive information concerning its operations or performance that would justify the price movement. The company confirmed it has no extraordinary events to report that could be causing the share price rise and will intimate the exchange of any future developments as required under SEBI regulations.
The Exchange has sought clarification from Bandaram Pharma Packtech Ltd on July 6, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Others (Uncategorized) · 07 Jul 2026, 12:13 am
Receipt of Order
Others (Uncategorized) · 11 Jun 2026, 10:33 pm
Bandaram Pharma Packtech Revises Subsidiary's Order Value Downward Bandaram Pharma Packtech, on 11 Jun'26, revised the value of a work order received by its subsidiary, VSR Paper and Packaging Ltd. The order from the Government of Telangana for printing and distributing textbooks is now valued at Rs. 27.71 crore (2 orders), a downward revision from the previously announced Rs. 37.44 crore (4 orders) on 29 May'26. The company cited a typographical error for the correction. The contract is for the academic year 2026-27 and is scheduled for execution between Jun'26 and Aug'26.
Resignation of Whole-Time Director of the Company.
Change in Management · 05 Jun 2026, 10:51 pm
Bandaram Pharma Whole-time Director NSK Aakarsh Raj Resigns NSK Aakarsh Raj has resigned from his position as Whole-time Director of Bandaram Pharma Packtech Limited (BSE: 524602), effective 5th Jun'26. The resignation letter cited other professional and personal reasons for the departure. Raj confirmed there were no other material reasons for his resignation. This management change is a key event for shareholders to monitor for potential impacts on company strategy and operations.
Change in Management
Change in Management · 31 May 2026, 5:13 am
Bandaram Pharma Q4FY26 Results and Key Board Approvals Bandaram Pharma Packtech's board approved audited financial results for the quarter and year ended 31 Mar'26. On a consolidated basis, Q4FY26 revenue from operations was ₹2,625.92 lakhs, with a net profit of ₹8.66 lakhs. For the full year FY26, revenue stood at ₹6,292.32 lakhs, with a net profit of ₹44.81 lakhs. The board also appointed M/s. MGR & Co. as internal auditors for FY27. The statutory auditor issued a modified opinion on the consolidated financials due to offsetting debtors/creditors in a subsidiary.
Audited Financial Results for the Quarter and Year ended 31.03.2026
Financial Result · 31 May 2026, 5:08 am
Bandaram Pharma Packtech Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 2,626 (+209.3% YoY | +77.0% QoQ) ■ EBITDA: 81.5 (+51.3% YoY | -18.5% QoQ) ■ EBITDA Margin (%): 3.1 (-324 bps YoY | -364 bps QoQ) ■ PAT: 8.7 (-44.8% YoY | -75.2% QoQ) ■ EPS (INR): 0.05 (-61.5% YoY | -73.7% QoQ)
Receipt of order
Others (Uncategorized) · 29 May 2026, 9:16 pm
Bandaram Pharma Subsidiary Wins ₹38.69 Crore Order for Textbook Materials Bandaram Pharma Packtech's material subsidiary, VSR Paper and Packaging, has secured a domestic work order worth ₹3,86,85,410 from M/s S. A. Printers. The order involves supplying paper, board, and other materials for printing and distributing textbooks for the 2026-27 academic year. The contract is scheduled for execution between Jun'26 and Aug'26. The transaction does not involve any promoter group entities or related parties.
Receipt of order
Others (Uncategorized) · 29 May 2026, 9:14 pm
Bandaram Pharma Subsidiary Secures ₹5.87 Crore Order for Textbook Materials Bandaram Pharma Packtech's material subsidiary, VSR Paper and Packaging Ltd, received an order worth ₹5.87 Cr from Vijayaa Print Solutions on 29 May'26. The domestic work order involves supplying paper, board, and other materials for printing and distributing textbooks for the 2026-27 academic year. The contract is scheduled for execution between Jun'26 and Aug'26. The transaction does not involve any promoter group interest or related parties, ensuring it is conducted at arm's length.
Receipt of Order
Others (Uncategorized) · 29 May 2026, 9:12 pm
Bandaram Pharma Secures Major Textbook Order from Telangana Govt Bandaram Pharma Packtech’s material subsidiary, VSR Paper and Packaging, has received two work orders from the Government of Telangana. The orders, dated 29 May'26, are for printing and distributing textbooks for the 2026-27 academic year. Work Order 1 is valued at Rs. 26.79 Cr for 3.28 Mn books, and Work Order 2 is valued at Rs. 91.84 Lakhs for 99.5k books. The total value of these orders is Rs. 27.71 Cr. The project is scheduled for execution between Jun'26 and Aug'26.
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial ....
Intimation · 30 May 2026, 5:30 am
Bandaram Pharma Board Meeting on May 30 to Approve Q4 and FY26 Financials Bandaram Pharma Packtech Ltd (BSE: 524602) has scheduled a Board Meeting for 30th May'26. The primary agenda is to consider and approve the audited standalone and consolidated financial statements for the quarter and fiscal year ended 31st Mar'26. The Board will also review the corresponding audit reports for the same period.
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Others (Uncategorized) · 01 May 2026, 12:04 am
Bandaram Pharma States It Does Not Qualify as a Large Corporate On 30 Apr'26, Bandaram Pharma Packtech Limited informed the exchange that it does not fall under the classification of a "Large Corporate" (LC) as defined by the SEBI circular dated 19 Oct'23. This classification relates to mandatory fundraising through debt securities. Consequently, the company has no mandatory borrowing requirements or associated penalties for FY26. The filing confirms its non-LC status, making the provisions of the circular not applicable.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 30 Apr 2026, 11:59 pm
Bandaram Pharma Does Not Qualify as a "Large Corporate" for FY27 Bandaram Pharma Packtech Ltd has informed the exchange that it does not qualify as a "Large Corporate" under SEBI's framework for FY27. The company meets the listing requirement but fails to meet the other criteria: outstanding long-term borrowings were only ₹3.48 Cr as of Mar'26, significantly below the ₹1,000 Cr threshold. Additionally, the company did not have the required credit rating of "AA" or above. Consequently, the mandatory borrowing requirements for Large Corporates are not applicable to the company.
Scrutinizer''s Report for the EGM of the company for the FY 2026-27 held on 27.04.2026
Extra Ordinary General Meeting · 27 Apr 2026, 7:24 pm
Bandaram Pharma Shareholders Approve All EGM Resolutions with Requisite Majority Bandaram Pharma Packtech Limited (BSE: 524602) announced that all resolutions at its EGM on 27th Apr'26 were passed with the requisite majority. Shareholders approved the appointment of Mr. Eswar Reddy Putturu as an Independent Director with 100% of valid votes in favor. They also approved two separate ordinary resolutions for material related party transactions with subsidiary VSR Paper and Packaging Limited. Both RPT resolutions passed with 100% of valid votes in favor, while 450,000 votes were declared invalid for each.